Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Successful and On-going Long-Term Disease Control (>24 Months) with Gilteritinib in an ALK+ NSCLC Patient with Brain Metastasis Who Has Progressed on Multiple ALK TKIs. A Case Report and Review of Literature on Gilteritnib

Saved in:
Bibliographic Details
Published in:Lung Cancer: Targets and Therapy
Format: Online Article RSS Article
Published: 2025
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867301673208119297
collection WordPress RSS
FRELIP Feed Integration
container_title Lung Cancer: Targets and Therapy
description
discipline_display Respiratory Diseases
discipline_facet Respiratory Diseases
format Online Article
RSS Article
genre Journal Article
id rss_article:58419
institution FRELIP
journal_source_facet Lung Cancer: Targets and Therapy
publishDate 2025
publishDateSort 2025
record_format rss_article
spellingShingle Successful and On-going Long-Term Disease Control (>24 Months) with Gilteritinib in an ALK+ NSCLC Patient with Brain Metastasis Who Has Progressed on Multiple ALK TKIs. A Case Report and Review of Literature on Gilteritnib
Respiratory Diseases
General
Respiratory Diseases
sub_discipline_display General
sub_discipline_facet General
subject_display Respiratory Diseases
General
Respiratory Diseases
Respiratory Diseases
General
Respiratory Diseases
subject_facet Respiratory Diseases
General
Respiratory Diseases
title Successful and On-going Long-Term Disease Control (>24 Months) with Gilteritinib in an ALK+ NSCLC Patient with Brain Metastasis Who Has Progressed on Multiple ALK TKIs. A Case Report and Review of Literature on Gilteritnib
title_auth Successful and On-going Long-Term Disease Control (>24 Months) with Gilteritinib in an ALK+ NSCLC Patient with Brain Metastasis Who Has Progressed on Multiple ALK TKIs. A Case Report and Review of Literature on Gilteritnib
title_full Successful and On-going Long-Term Disease Control (>24 Months) with Gilteritinib in an ALK+ NSCLC Patient with Brain Metastasis Who Has Progressed on Multiple ALK TKIs. A Case Report and Review of Literature on Gilteritnib
title_fullStr Successful and On-going Long-Term Disease Control (>24 Months) with Gilteritinib in an ALK+ NSCLC Patient with Brain Metastasis Who Has Progressed on Multiple ALK TKIs. A Case Report and Review of Literature on Gilteritnib
title_full_unstemmed Successful and On-going Long-Term Disease Control (>24 Months) with Gilteritinib in an ALK+ NSCLC Patient with Brain Metastasis Who Has Progressed on Multiple ALK TKIs. A Case Report and Review of Literature on Gilteritnib
title_short Successful and On-going Long-Term Disease Control (>24 Months) with Gilteritinib in an ALK+ NSCLC Patient with Brain Metastasis Who Has Progressed on Multiple ALK TKIs. A Case Report and Review of Literature on Gilteritnib
title_sort successful and on-going long-term disease control (>24 months) with gilteritinib in an alk+ nsclc patient with brain metastasis who has progressed on multiple alk tkis. a case report and review of literature on gilteritnib
topic Respiratory Diseases
General
Respiratory Diseases
url https://www.dovepress.com/successful-and-on-going-long-term-disease-control-24-months-with-gilte-peer-reviewed-fulltext-article-LCTT